November 4-6, 2025

Boston Convention and Exhibition Center, Boston, MA

Innovation, Technology and Performance for Drug Safety Professionals and Partners

ENQUIRE TO
SPONSOR/EXHIBIT

TICKETS FROM $200
REGISTER NOW

THE #1 DRUG SAFETY EVENT IN THE AMERICAS

2,000+

Attendees

200+

Speakers

100+

Exhibitors

10

Tracks

3

Days

From early-stage safety assessments to post-market safety monitoring, the World Drug Safety Congress Americas spans the entire spectrum of drug safety. It is where scientific innovation, regulatory frameworks, and industry collaboration intersect to drive meaningful advancements in patient safety and global health.

Join the largest commercial gathering of PV professionals in the world November 4-6, 2025 for the most up to date, keynote-driven content surrounding the drug safety and pharmacovigilance space.

ENQUIRE TO GET INVOLVED

The World Drug Safety Congress Americas is the defining event for the drug safety and pharmacovigilance space globally

THE CONFERENCE

Showcase the latest developments in the drug safety and PV space from top thought leaders in the industry.

APPLY TO SPEAK

THE EXHIBITION

Discover innovative products and solutions revolutionizing the future of drug safety and patient safety.

APPLY TO EXHIBIT

NETWORKING

Connect with industry leaders from around the world to advance drug safety and PV to safe guard public health.

GET YOUR TICKET

Highlighted Speakers

Han Ma
Chief Safety Officer
BeiGene USA, Inc.

Han Ma speaking at World Drug Safety Congress

Serban Ghiorghiu
Chief Safety Officer

AstraZeneca

Serban Ghiorghiu speaking at speaking at World Drug Safety Congress

Rania Mouchantaf, PhD
Executive Director
Health Canada

Rania Mouchantaf, PhD speaking at World Drug Safety Congress

Peter Hjelmstrom
Director and CEO
Uppsala Monitoring Centre

Peter Hjelmstrom speaking at World Drug Safety Congress

Jose Vega
Chief Safety Officer
Moderna Therapeutics

Jose Vega speaking at World Drug Safety Congress

Yvonne Nanciu
Country Head, PV, Deputy EU QPPV
Bayer

Yvonne Nanciu speaking at World Drug Safety Congress

Badrish Patel
VP, Global Drug Safety & PV
Jazz Pharmaceuticals

Badrish Patel speaking at World Drug Safety Congress

Claudia Manzo
Head of the Office of Risk Management PV & Patient Safety
AbbVie

Claudia Manzo speaking at World Drug Safety Congress

Mamiko Kasho
Executive Director, Head of Pharmacovigilance Operations
Eisai

Mamiko Kasho speaking at World Drug Safety Congress

Felix Arellano
Global Head of PV & Drug Safety
Roche

Felix Arellano speaking at speaking at World Drug Safety Congress

Reema Mehta
VP, Head of Risk Assessment & Management
Pfizer

Reema Mehta speaking at World Drug Safety Congress

Badrish Patel
Vice President, Global Drug Safety and Pharmacovigilance
Jazz Pharmaceuticals

SEE MORE SPEAKERS

ENQUIRE TO SPONSOR

The Start-to-Finish of Drug Safety

From quality assurance and compliance to AI & automation and patient centricity

AI & Automation

AI & Automation
Discover how artificial intelligence and automation are transforming pharmacovigilance processes, enhancing efficiency, accuracy, and drug safety monitoring.

Global PV

Global PV
Explore global trends in pharmacovigilance and how international regulatory requirements shape drug safety practices.

Regulatory

Regulatory
Stay updated on the latest regulatory developments in drug safety internationally and how to ensure compliance with evolving guidelines

Safety Risk Management

Safety Risk Management
Learn advanced strategies for identifying, assessing, and mitigating risks throughout the drug development lifecycle

Next Gen Tech & Data

Next Gen Tech & Data
Learn first-hand how next-generation technologies and data analytics are revolutionizing pharmacovigilance and enhancing drug safety monitoring.

Real-World Evidence & Data Analytics

Real-World Evidence & Data Analytics
Understand the role of real-world data in generating insights that improve drug safety and patient outcomes.

Patient Centricity

Patient Centricity
Dive into how placing patients at the center of drug safety efforts improves care, reporting, and risk management

PV Education & Training

PV Education & Training
Gain insights into effective PV training programs that ensure a skilled and knowledgeable workforce in drug safety.

PV Outsourcing

PV Outsourcing
Discuss the benefits and challenges of outsourcing pharmacovigilance operations to external partners.

Innovation & Partnerships

Innovation & Partnerships
Learn how collaborations and partnerships are driving innovation in drug safety and pharmacovigilance.

Compliance

Compliance
Hear best practices on navigating the complexities of ensuring drug safety compliance with stringent local and global regulations.

Quality Assurance

Quality Assurance
Explore the importance of maintaining high-quality standards in pharmacovigilance to protect patient safety.

Safety in Advanced Therapies

Safety in Advanced Therapies
Address the unique safety challenges posed by advanced therapies such as gene and cell therapies.

Vaccine Safety

Vaccine Safety
Discuss the latest strategies and challenges in monitoring the safety of vaccines in a rapidly evolving landscape.

MedTech

MedTech
Understand the intersection of pharmacovigilance and medical technology, focusing on the safety monitoring of medical devices.

ENQUIRE TO SPEAK

“Well organized meeting, facilitating timely comprehensive discussions on important safety topics. Highly recommended.”

– Vice President, Medical Global Patient Safety, Eli Lilly and Company

Join us in Boston

November 4-6, 2025

REGISTER TODAY

Innovation, Technology and Performance for Drug Safety Professionals and Partners

THE #1 DRUG SAFETY EVENT IN THE AMERICAS

2,000+

200+

100+

10

3

The World Drug Safety Congress Americas is the defining event for the drug safety and pharmacovigilance space globally

Highlighted Speakers

Sponsors & Exhibitors

The Start-to-Finish of Drug Safety

From quality assurance and compliance to AI & automation and patient centricity

“Well organized meeting, facilitating timely comprehensive discussions on important safety topics. Highly recommended.”

– Vice President, Medical Global Patient Safety, Eli Lilly and Company

Join us in Boston

November 4-6, 2025

Get Involved At Drug Safety Congress Americas

CONNECT WITH US

To Sponsor

Semen Sen
semen.sen@terrapinn.com
t/ + 646-619-1793

To Speak

Kaylee Nguyen
kaylee.nguyen@terrapinn.com

Marketing & Press

Emily Ngai
emily.ngai@terrapinn.com

Created by

Innovation, Technology and Performance for Drug Safety Professionals and Partners

THE #1 DRUG SAFETY EVENT IN THE AMERICAS

2,000+

200+

100+

10

3

The World Drug Safety Congress Americas is the defining event for the drug safety and pharmacovigilance space globally

Highlighted Speakers

Sponsors & Exhibitors

The Start-to-Finish of Drug Safety

From quality assurance and compliance to AI & automation and patient centricity

“Well organized meeting, facilitating timely comprehensive discussions on important safety topics. Highly recommended.”

– Vice President, Medical Global Patient Safety, Eli Lilly and Company

Join us in Boston

November 4-6, 2025

Get Involved At Drug Safety Congress Americas

CONNECT WITH US

To Sponsor

Semen Sen semen.sen@terrapinn.com t/ + 646-619-1793

To Speak

Kaylee Nguyen kaylee.nguyen@terrapinn.com

Marketing & Press

Emily Ngai emily.ngai@terrapinn.com

Created by

Semen Sen
semen.sen@terrapinn.com
t/ + 646-619-1793

Kaylee Nguyen
kaylee.nguyen@terrapinn.com

Emily Ngai
emily.ngai@terrapinn.com